Health Journal Online

Category: Diseases & Conditions

  • Repeated Weight Loss and Regain Was Tied to Four Times More Thigh Muscle Loss in a Four-Year MRI Study

    Repeated Weight Loss and Regain Was Tied to Four Times More Thigh Muscle Loss in a Four-Year MRI Study

    People whose weight repeatedly went down and back up over four years lost nearly four times as much thigh muscle as people whose weight stayed steady, and they ended the period weighing about the same as when they started.

    That is the central finding of an imaging study of 1,433 middle-aged adults, published in Radiology by a team from the University of California, San Francisco, and described in a UCSF release.

    The number that matters: weight cyclers lost about 3.7% of thigh muscle volume over 48 months, compared with about 1% among people whose weight remained relatively stable.

    Two clarifications belong immediately. This is an observational study, not a trial, so it shows an association rather than proof that weight cycling caused the muscle loss. And nobody in it was taking a GLP-1 medication, which matters given how the finding is being framed elsewhere.

    What the MRI Study Measured

    The researchers drew on the Osteoarthritis Initiative, a long-running, NIH-funded cohort of adults at elevated risk for knee osteoarthritis. That is a specific population, not a general sample of American adults.

    Participants received MRI scans over four years. Using artificial intelligence to analyze the images, the team measured thigh muscle volume, fat located within the muscle, and fat surrounding the knee. Direct imaging is the methodological advance here, since most weight-cycling research has relied on scales, body-composition estimates, or self-reported dieting history.

    The 3.7% versus 1% gap held after the researchers accounted for age, sex, baseline body mass index, physical activity, diet, and other health factors. The published conclusion states that among participants who maintained stable weight over 48 months, “weight cycling was associated with an increased loss of MRI-based thigh muscle volume.”

    Notably, the team found no evidence of a difference between groups in the change in intermuscular fat proportion. The signal was in muscle volume, not fat infiltration.

    Why the Muscle Did Not Come Back

    The detail driving the coverage is directional. Weight came back. Muscle did not.

    “When people’s weight cycled, they lost tremendous amounts of muscle along with the fat,” said Thomas Link, MD, PhD, professor of radiology, who led the study with co-first authors Adrian A. Marth, MD, and Gabby Joseph, PhD. He noted the muscle was not regained.

    The mechanism is plausible and long suspected. Weight lost through calorie restriction includes lean tissue as well as fat, and regain is more efficiently deposited as fat than as muscle unless resistance training and adequate protein intake are part of the process. Repeat that cycle several times and the composition of a stable-looking body weight shifts.

    The illustrative case UCSF released is striking but is a single participant, not a study result: one 62-year-old man’s thigh muscle volume fell 16% over 48 months while his BMI dropped only 1.6%. It shows how invisible this can be on a bathroom scale.

    Worth stating carefully: the study followed people for four years. It did not establish that the loss is permanent, only that it had not reversed within that window.

    The GLP-1 Question the Study Did Not Answer

    This study is being widely presented as a warning about weight-loss drugs. It is not one, and the distinction matters for anyone currently taking these medications.

    No participant was on a GLP-1 medication. Link’s own framing was that the insight addresses a question likely to grow in importance as more people start and stop weight-loss therapies, which is a hypothesis about relevance, not a finding about the drugs.

    That said, the question is legitimate. People do stop and restart GLP-1s because of cost, coverage changes and side effects, and that pattern resembles weight cycling. MedicalDaily has previously reported on concerns about muscle loss and malnutrition in adults over 65 taking GLP-1 drugs and on the absence of muscle, bone and nutrition screening requirements in the Medicare GLP-1 Bridge program.

    What this study adds to that conversation is imaging evidence that repeated cycles compound muscle loss in people not on medication at all. What it does not do is quantify anything about GLP-1 users, and no professional society has issued new guidance in response.

    What the Study Cannot Tell You

    The limitations are worth holding onto.

    It is observational. People who cycle weight may differ from people who do not in ways the adjustments did not capture, including illness, medication use, and eating patterns.

    The cohort was middle-aged adults at risk for knee osteoarthritis, a group that may be less mobile and more prone to muscle loss than the general population. The findings may not transfer cleanly to younger or healthier people.

    Thigh muscle volume is a reasonable proxy for overall skeletal muscle but is not the same as measured strength, physical function, or fall risk. The study did not report those outcomes.

    And four years is the observation window. Longer follow-up would be needed to say anything about permanence.

    What to Do With This If You Are Losing Weight

    Nobody should stop a prescribed medication because of this study. That includes GLP-1 drugs taken for diabetes or cardiovascular risk, where the consequences of stopping are concrete and immediate.

    The reasonable response is to make muscle preservation part of any weight-loss plan rather than an afterthought. That generally means resistance training at least twice weekly and adequate protein intake, and it is worth asking a clinician or a registered dietitian what those targets should be for your age, kidney function and medical history rather than adopting numbers from an article.

    People who anticipate a coverage or cost interruption in a weight-loss medication can raise it with a prescriber before it happens, since an unplanned stop and restart is the pattern this research suggests is worth avoiding.

    Simple in-office measures of muscle function, including grip strength and a chair-stand test, are available and inexpensive if you want a baseline.

    Researchers will need studies that follow people through medication-driven weight loss and regain, with imaging, to answer the question this one raised. That work has not been done.

    Frequently Asked Questions

    What did the study find? Adults whose weight repeatedly fluctuated over four years lost about 3.7% of thigh muscle volume, compared with about 1% among adults whose weight stayed relatively stable.

    Does this prove weight cycling causes muscle loss? No. This was an observational imaging study. It found an association after adjusting for several factors, but it cannot establish cause.

    Was the muscle loss permanent? The study found the muscle had not returned within its four-year window. It did not follow participants long enough to establish permanence.

    Did the study include people on GLP-1 drugs? No. No participant was taking a weight-loss medication. The connection to GLP-1 use is a question the lead author raised, not something the study measured.

    Who was studied? 1,433 middle-aged adults enrolled in the Osteoarthritis Initiative, a cohort of people at elevated risk for knee osteoarthritis. Results may not apply equally to younger or healthier populations.

    Should someone stop a weight-loss medication because of this? No. Do not stop or change a prescribed medication based on a news report. Discuss any concerns with the prescribing clinician.

    How can someone protect muscle during weight loss? Resistance training and adequate protein intake are the established approaches. Specific targets should come from a clinician or registered dietitian, not from an article.

    Source link

  • New Research Finds Semaglutide Users Held Lower Calorie Intake For More Than A Year

    New Research Finds Semaglutide Users Held Lower Calorie Intake For More Than A Year

    What the Study Measured

    A question that comes up constantly in weight management clinics now has a direct measurement behind it: if the hunger comes back, has the drug stopped working?

    Penn Medicine researchers ran a 60-week trial in 120 adults who were overweight or had obesity, assigning them to once-weekly semaglutide at 2.4 mg or placebo, with regular lifestyle counseling in both groups. The design’s strength is that it did not rely on what people said about their appetite. It measured what they ate.

    At baseline and again at weeks 20, 40, and 60, participants completed a five-hour laboratory assessment. After a standardized breakfast, they were offered lunch and told to eat until they felt comfortably full. Researchers weighed and counted the calories consumed.

    Across those follow-up assessments through week 60, participants taking semaglutide ate about 24 to 30 percent fewer calories than those on placebo, according to Penn Medicine. Weight followed. The semaglutide group lost an average of 15.1 percent of initial body weight at week 60, against 3.4 percent for placebo.

    The Gap Between Feeling Hungry and Eating More

    The finding that makes this study useful is the mismatch between what people reported and what they did.

    During the first 20 weeks, participants on semaglutide reported less hunger, greater appetite control and fewer thoughts about food, the sensation many patients call food noise. By weeks 40 and 60, the differences between the semaglutide and placebo groups on many of those subjective measures were no longer statistically significant.

    The calorie difference persisted anyway.

    “This study highlights an important distinction between people’s perceptions of their appetite and how they actually eat,” said Thomas A. Wadden, PhD, a professor of psychology in psychiatry and former director of Penn’s Center for Weight and Eating Disorders. “People taking semaglutide for weight loss often notice dramatic reductions in hunger and food noise when they begin this treatment. If those sensations gradually become less noticeable, some may incorrectly assume the medication is no longer effective.“

    Lead author Jena S. Tronieri, PhD, a senior research investigator at the center, framed the practical consequence directly. “Many patients worry that their medication has stopped working if they notice some return of hunger after the first several months,” she said. “Our findings show that even when people feel some of those sensations returning, semaglutide continues to help them eat less. That sustained reduction in calorie intake appears to be a key reason why weight loss is maintained over time.“

    There is a plausible explanation for the divergence that the study does not settle. Subjective hunger ratings are relative to a person’s own recent experience, and a body 15 percent lighter has different baseline sensations than it did a year earlier. Feeling hungrier than you did at week four is not the same as eating as you did before treatment.

    What This Does Not Tell You

    Several limits deserve to sit here rather than at the end, because they bound what the result can be used for.

    The single largest one is that this study says nothing about stopping. Every participant analyzed was on treatment. It does not measure what happens to calorie intake after discontinuation, which is the question behind most of the current anxiety about these drugs. Separate research has consistently found weight regain after stopping.

    The sample was 120 people. That is adequate for a controlled laboratory feeding study and small for drawing conclusions about population-level behavior. The trial also ran 60 weeks, so it does not describe year three or year five.

    The laboratory meal is a proxy, not real life. Participants ate a standardized breakfast in a research setting and then a single test lunch under observation. That design controls variables well and does not capture evening eating, weekend eating, restaurant portions, stress eating or the social context in which most calories are actually consumed.

    Both groups received lifestyle counseling throughout, so the comparison is semaglutide plus counseling against placebo plus counseling, not against no intervention.

    The study was supported in part by a Novo Nordisk research grant through the company’s Investigator Sponsored Studies Program. Penn states that Novo Nordisk played no part in the conception, conduct, analysis, or reporting of the study.

    Why It Matters for People Considering Stopping

    The clinical relevance here is a decision, not a data point.

    Patients who conclude their medication has quit working sometimes stop taking it, sometimes stop refilling because they no longer see the point of the cost, and sometimes ask for a dose increase they may not need. This study suggests at least one of those inferences may rest on a misreading of the evidence available to the patient, which is their own sense of hunger.

    “Our results suggest that patients may experience a partial return of appetite sensations over time, without losing the medication’s benefit of continuing to reduce calorie intake, which is needed to maintain their new, lower body weight,” Tronieri said. “Understanding that can help set realistic expectations and may encourage people to stay on treatment long term, as approved by the U.S. Food and Drug Administration and recommended by the treatment guidelines of numerous professional societies.”

    That framing comes from researchers whose work is partly industry-funded, and readers should weigh it accordingly. It is also consistent with how obesity is defined in current clinical guidance, as a chronic condition managed rather than cured.

    What Patients Should Take From It

    Nobody should start, stop or change a dose based on this study, and the most useful action it supports is a conversation rather than a decision.

    If your hunger has returned somewhat after several months on semaglutide, that is a documented pattern and not automatically a sign of treatment failure. Weight trajectory, waist measurement, blood pressure, lipids and glucose are more reliable indicators of whether the medication is doing its job than the subjective sense of appetite.

    If weight has plateaued or is climbing, that is worth raising with a prescriber, who can look at dose, adherence, other medications, sleep, alcohol and activity before concluding anything about the drug.

    Anyone considering stopping because of cost, side effects, or coverage changes should have that conversation before stopping rather than after, since abrupt discontinuation carries a well-documented pattern of regain.

    The next questions researchers will need to answer are what calorie intake looks like beyond 60 weeks, what it looks like after discontinuation, and whether the same pattern holds for tirzepatide and the newer oral agents. MedicalDaily will report follow-up analyses as they publish.

    Frequently Asked Questions

    What did the study find? Adults taking semaglutide ate 24 to 30 percent fewer calories than those on placebo at laboratory assessments through week 60, and lost 15.1 percent of body weight versus 3.4 percent.

    Does hunger really come back? Reported hunger, appetite control and food noise differed clearly from placebo at 20 weeks, but many of those differences were no longer statistically significant by weeks 40 and 60.

    So has the drug stopped working if I feel hungrier? Not necessarily. In this trial, calorie intake stayed lower even as subjective appetite differences faded. Weight trend is a better indicator than hunger.

    How big was the study? 120 adults with overweight or obesity, over 60 weeks.

    Does this tell me what happens if I stop? No. Everyone analyzed was on treatment. The study does not address discontinuation.

    Who funded it? It was supported in part by a Novo Nordisk research grant. Penn states the company had no role in the study’s conception, conduct, analysis or reporting.

    Should I change my dose? Not on your own. Discuss weight trajectory and any concerns with your prescriber.

    Source link

  • FDA Panel Ends Peptide Review Backing Six of Seven, with Emideltide Rejected in a 6 to 7 Vote

    FDA Panel Ends Peptide Review Backing Six of Seven, with Emideltide Rejected in a 6 to 7 Vote

    The meeting is over, and the final tally is not what the first day suggested. By the close of Friday afternoon, the FDA’s Pharmacy Compounding Advisory Committee had recommended adding six of the seven peptides it reviewed to the 503A Bulks List, and had voted against one.

    Emideltide, also known as delta sleep-inducing peptide or DSIP, failed on a 6 to 7 vote with one abstention. It had been proposed for insomnia, narcotic dependence, and opioid withdrawal. Epitalon cleared 7 to 5 with one abstention for insomnia. Semax cleared 8 to 5 for cerebral ischemia, migraine, and trigeminal neuralgia.

    That single rejection is the genuinely new fact, and it is the most informative one, because it shows where a narrowly divided panel found the evidence too thin even in a week when it overrode FDA staff on everything else.

    Why This Update Matters

    For a household deciding whether to spend money on a compounded peptide, the practical question is not which way a committee voted. It is what a favorable vote actually buys you, and the honest answer is: nothing yet, and less than the marketing will claim.

    The votes are recommendations. The FDA makes the final determination through notice-and-comment rulemaking, a process that commonly takes months. Nothing about a patient’s legal access changed this week.

    There is also a cost consequence worth stating plainly. Compounded drugs are generally not covered by insurance, so anyone who eventually obtains these peptides through a pharmacy would pay out of pocket.

    What Changed Since MedicalDaily’s Previous Report

    MedicalDaily previously reported on the first day of voting, when the panel backed BPC-157, KPV, TB-500 and MOTS-C over the objections of FDA’s own scientists. At that point, three peptides remained undecided, and the panel’s overall posture was unknown.

    What is different now is that the full slate is settled and the pattern is visible. FDA career staff had recommended against all seven. The committee agreed with the agency exactly once.

    What We Know So Far

    On the first day, BPC-157, KPV and TB-500 each passed 8 to 6 with one abstention. MOTS-C passed 7 to 5 with two abstentions. The committee held 15 voting seats for the meeting.

    None of the seven peptides is part of a United States Pharmacopeia monograph or a component of an FDA-approved drug product. Most were restricted from compounding under a 2023 reclassification in which the agency said they may present significant safety risks.

    FDA’s briefing materials flagged specific problems by substance, including adverse event reports following BPC-157 injection, uncertainty about carcinogenicity connected to epitalon’s mechanism, and anticoagulant and stimulant-potentiation signals for semax. On emideltide, the agency cited inadequate characterization and the potential for peptide-related impurities.

    What the Committee Members Said

    Speaking on the emideltide vote, FDA’s Katie Park said there is “a lack of safety and efficacy data to support using emideltide” for the proposed uses.

    John Hertig, board chair of the Collaborative for Evidence-Based Medicines, told the panel during the public hearing that “there is a significant lack of evidence,” noting the most recent study he could identify was decades old.

    Committee member Kevin Zacharoff, an anesthesiologist and clinical assistant professor at Stony Brook University’s Renaissance School of Medicine, explained his no vote by saying it was “impossible for me not to take FDA’s recommendations to heart” on safety and efficacy. William Zamboni, a pharmacologist at the University of North Carolina, cited a significant lack of safety data in voting against epitalon.

    Members voting yes framed it differently. Pharmacist David Pope of XiFin Pharmacy Solutions said prescriber and pharmacist judgment is central to deciding whether a peptide fits a given patient. Former Puerto Rico governor Ricardo Rosselló told the panel during the open hearing that “there is a cost of doing nothing,” arguing the 2023 restrictions abandoned standards rather than raising them.

    What a Compounded Preparation Is, and Is Not

    This is the distinction most likely to be lost in the coming weeks.

    An FDA-approved drug has cleared adequate and well-controlled trials showing it works and is acceptably safe for a defined use, and it is made in facilities the FDA inspects against manufacturing standards. A compounded preparation made under Section 503A is produced by a state-licensed pharmacy for an individual patient with a prescription, and the FDA does not review it for safety or effectiveness at all.

    Adding a substance to the 503A Bulks List makes it legal to compound. It does not make it proven. And once a substance is on the list, a clinician may prescribe it outside the narrow indication the committee reviewed, so a peptide evaluated only for ulcerative colitis could be prescribed for other purposes.

    Who Faces the Greatest Risk

    The people most exposed are those already buying peptides from online sellers labeling them as research chemicals, where purity, sterility, and dose are unverified. Advocates for the change argue that regulated pharmacy access is safer than that market, which is a reasonable argument about relative risk rather than a claim of proven benefit.

    Athletes face a distinct problem. TB-500 and MOTS-C appear on World Anti-Doping Agency prohibited lists, and a legal prescription would not prevent an anti-doping violation.

    People with cancer histories, clotting disorders, or those taking anticoagulants have specific reasons to raise the FDA’s flagged concerns with a physician before considering any of these compounds.

    What Remains Unknown

    For every one of these seven peptides, the fundamental gap is the same: none has completed the large randomized human trials that support a standard FDA approval. Effectiveness for the proposed uses is not established. Long-term safety is not established. FDA staff also raised basic characterization questions, meaning the identity and consistency of the raw substance itself is not fully settled.

    The agency has not said when it will respond to the recommendations, or whether it will accept them.

    What You Can Do Now

    Anyone considering these compounds should treat marketing that uses the words FDA approved as a red flag, because none of these peptides is approved and none became approved this week. Discuss any peptide use with a physician who knows your full medication list.

    Do not start, stop, or change a prescribed medication based on an advisory vote. Patients currently obtaining peptides from gray-market sellers should raise that with a clinician, since product contents may not match the label.

    What Happens Next

    The FDA will decide whether to act on the recommendations. Any change requires proposed rulemaking with a public comment period, and observers of the process commonly estimate eight to twelve months before legality is unambiguous. The public docket for this meeting remains the place where written comments were filed. MedicalDaily will track the agency’s formal response.

    The Bottom Line

    The newest confirmed fact is that the panel finished by rejecting emideltide 6 to 7 while backing six other peptides, all against FDA staff recommendations. The people most affected are patients already using or considering these compounds, and the most reasonable step is a conversation with a physician rather than a purchase. The central uncertainty is whether the FDA follows a committee it has occasionally overruled before, and the next development is the agency’s formal response.

    Developing Story Timeline

    July 24, 2026: The committee rejects emideltide 6 to 7 with one abstention, recommends epitalon 7 to 5 and semax 8 to 5, closing the meeting with six of seven peptides endorsed.

    July 23, 2026: The committee recommends BPC-157, KPV, and TB-500 at 8 to 6 with one abstention, and MOTS-C at 7 to 5 with two abstentions.

    April 15, 2026: FDA publishes the Federal Register notice announcing the two-day meeting and opening the public docket.

    2023: FDA reclassification restricts compounding of these peptides, citing potential significant safety risks.

    Source link

  • Oregon Air Quality Advisory Extended Through Today as Wildfires Blanket Multiple Counties in Hazardous Smoke

    Oregon Air Quality Advisory Extended Through Today as Wildfires Blanket Multiple Counties in Hazardous Smoke

    The Oregon Department of Environmental Quality extended its air quality advisory on Wednesday, July 22, 2026, for a broad stretch of eastern and central Oregon, keeping health warnings active through at least Friday afternoon, July 24 — today. The advisory, which has now been extended three times since its original Monday end date, covers Baker, Crook, Deschutes, northern Harney, Grant, Jefferson, northern Malheur, Morrow, Union, southern Umatilla, and Wheeler counties due to smoke from multiple wildfires burning across southern, central, and eastern Oregon.

    The DEQ also identified intermittent smoke conditions in adjacent areas including Clackamas, eastern Douglas, northern Jackson, Klamath, Lake, and Wallowa counties through Friday afternoon. Separately, the DEQ issued an ozone smog advisory earlier this week for the Portland metro area, Salem, Hermiston, and Ontario, running through Wednesday evening.

    Why This Matters

    Wildfire smoke is not the same as the kind of air pollution most people think of from traffic or industry. Its most dangerous component is fine particulate matter, known as PM2.5 — particles less than 2.5 microns in diameter, small enough to bypass the body’s upper respiratory defenses and penetrate deeply into the lungs. Once inhaled, PM2.5 can enter the bloodstream and reach the heart, brain, and other organs.

    For people with asthma, chronic obstructive pulmonary disease, heart disease, or other cardiovascular or respiratory conditions, even moderate smoke exposure can trigger exacerbations that require emergency care. Children and pregnant people face distinct risks: children’s lungs are still developing, and PM2.5 exposure in pregnancy has been associated with preterm birth and low birth weight in multiple studies. Older adults face heightened cardiovascular risk from PM2.5 exposure even without pre-existing lung disease.

    As the DEQ’s advisory states, air quality may reach unhealthy levels in affected areas, with conditions capable of changing rapidly depending on wind and fire behavior.

    What We Know So Far

    Air quality was measured as “unhealthy” in Prineville, Pendleton, La Grande, and Baker City as of the afternoon of July 20, 2026, according to Central Oregon Daily. Under DEQ’s six-tier classification system, “unhealthy” means the general public may begin to experience health effects, while sensitive groups face serious health risks.

    The advisory was first issued for a subset of counties and was originally scheduled to end Monday, July 20. It was extended to Wednesday, then to at least Friday afternoon, July 24, reflecting the persistence of the wildfire smoke and the failure of weather conditions to clear affected areas.

    The smoke sources are multiple wildfires across southern, central, and eastern Oregon. Earlier in July, the East Evans Creek Fire in southern Oregon contributed to initial advisories before the smoke pattern expanded. The current advisory reflects a broader regional fire environment rather than a single named fire.

    Where the Risk Is Highest

    The counties under the active advisory — Baker, Crook, Deschutes, northern Harney, Grant, Jefferson, northern Malheur, Morrow, Union, southern Umatilla, and Wheeler — cover a wide stretch of eastern and central Oregon, including Bend (Deschutes County), La Grande (Union County), Pendleton (Umatilla County), and John Day (Grant County).

    Residents in these communities who live or work outdoors, those who depend on cooling by opening windows, and those with limited access to air conditioning or air filtration face the highest cumulative exposure. Agricultural workers, construction workers, and others in outdoor occupations in affected counties face occupational exposure that cannot be avoided by staying indoors.

    The DEQ and partner agencies are continuing to monitor smoke conditions, and the advisory may be extended or expanded further depending on fire behavior and wind patterns.

    What Doctors and Experts Say

    DEQ spokesperson Jennifer Horton told KATU that residents most at risk should stay indoors during the hottest parts of the day when pollutant levels are typically highest. “If you’re able to stay indoors during the hottest parts of the day when ozone levels are going to be the highest, that will help alleviate some of those health conditions,” Horton said.

    For people with heart or lung conditions, the DEQ recommends consulting a health-care provider before wearing a respirator, as the exertion required to breathe through a properly sealed N95 can itself place demands on the cardiovascular system. People who use inhalers, bronchodilators, or other respiratory medications should ensure they have an adequate supply and access to those medications during extended smoke events.

    What the Evidence Shows — and What It Does Not

    PM2.5 from wildfire smoke is a well-established health hazard supported by decades of peer-reviewed research. Short-term spikes in PM2.5 are consistently associated with increases in emergency department visits for asthma, respiratory distress, and cardiac events. The health consequences scale with concentration and duration of exposure, meaning a multi-day advisory affecting a broad area carries more cumulative health risk than a brief spike.

    What is harder to quantify in real time is the specific PM2.5 concentration in any individual location, since wildfire smoke levels can change within hours depending on fire behavior, terrain, and wind. The DEQ’s official AQI data provides the most reliable real-time measurement available.

    Cloth masks, surgical masks, and dust masks do not protect against PM2.5. Only properly fitted NIOSH-approved N95 or P100 respirators can reduce inhalation of fine smoke particles, according to DEQ’s advisory guidance. Standard respirators do not come in sizes appropriate for children, meaning young children cannot be effectively protected by masking outdoors.

    Who Faces the Greatest Risk?

    People with asthma, COPD, emphysema, or other chronic obstructive or restrictive lung disease face the highest respiratory risk from wildfire PM2.5 exposure. People with heart disease or prior heart attack face elevated cardiovascular risk from smoke, including increased risk of arrhythmia and acute coronary events during high-exposure periods.

    Pregnant people face a distinct concern: PM2.5 exposure during pregnancy has been associated in published research with preterm birth, low birth weight, and adverse fetal lung development. Pregnant residents in affected counties should treat the advisory as applying to them even if they feel well.

    Children under the age of 14 and adults over 65 are classified as sensitive groups by the EPA, meaning they may experience effects at lower concentrations than healthy adults. Infants and toddlers face the highest vulnerability because their lung development is most active and they spend the most time in care settings that may rely on natural ventilation.

    Outdoor workers in affected counties face occupational exposure that indoor workers do not. Construction crews, farm workers, utility workers, and others who cannot work indoors should follow employer guidance on break frequency, access to clean air spaces, and symptom monitoring.

    Symptoms and Warning Signs to Watch For

    Wildfire smoke exposure can cause burning or irritated eyes, runny nose, sore throat, coughing, and shortness of breath in otherwise healthy people. These symptoms are generally mild and resolve when a person moves to cleaner air.

    For people with asthma or COPD, smoke can trigger wheezing, chest tightness, increased breathlessness, and reduced peak flow that may require additional use of rescue inhalers or other medications. Symptoms that do not respond to usual rescue medications, worsening shortness of breath at rest, chest pain, rapid heart rate, confusion, or loss of consciousness warrant urgent or emergency evaluation.

    People who experience new or worsening chest pain, pressure, or tightness during a smoke event — even without prior heart disease — should seek emergency care. Wildfire smoke has been associated in research with triggering acute cardiac events in people who did not know they had underlying heart disease.

    What You Can Do Now

    The most effective action for residents in affected counties is to stay indoors with windows and doors closed as much as possible. If your home has a central air system, set it to recirculate indoor air rather than drawing in outside air. A portable HEPA air purifier run in the room where you spend the most time can significantly reduce indoor PM2.5 concentrations.

    If you must go outdoors for essential activities, a properly fitted NIOSH-approved N95 respirator provides meaningful protection. Select a respirator with an N, R, or P designation alongside the number 95, 99, or 100. Surgical and cloth masks do not provide effective filtration for wildfire PM2.5. Respirators must form a tight seal against the face to work, which means they do not fit children.

    Check current air quality conditions before going outdoors at Oregon DEQ’s Air Quality Index, the Oregon Smoke Information Blog, or by downloading the free OregonAIR app. AQI updates are in near real-time and are the most reliable tool for assessing current local conditions.

    If you are experiencing worsening symptoms and do not have access to cleaner air at home, 211info.org maintains a directory of clean air shelter locations in Oregon. Search for “Wildfire Related Clean Air Shelters” or call 211 during business hours, 8 a.m. to 6 p.m.

    People with asthma or COPD should ensure their rescue inhaler and any controller medications are filled and accessible before an extended smoke event. If you have a written asthma or COPD action plan, review it with your health-care provider at your next appointment to include guidance on smoke days.

    Cost and Access: What Patients Should Know

    N95 respirators are available at most hardware stores, home improvement retailers, and online retailers at a cost of roughly $1 to $4 per mask when purchased in multipacks. For residents who cannot access or afford respirators, free clean air shelter locations are available through 211info.org. OHA-certified community health workers in some counties can also connect residents to local resources during declared air quality events.

    People who use prescription inhalers or respiratory medications and are running low should contact their pharmacy or prescriber as early as possible, as demand for rescue medications typically increases during extended smoke events. Many pharmacies can provide emergency supplies of maintenance inhalers for patients with active prescriptions.

    What Happens Next

    The DEQ advisory is scheduled through at least Friday afternoon, July 24, 2026 — today — but may be extended further depending on wildfire activity and weather patterns. DEQ and partner agencies are monitoring conditions continuously.

    Residents in affected counties should check oregonsmoke.org and the DEQ AQI tool periodically throughout the day, as smoke levels can shift within hours. MedicalDaily will note any further advisory extensions if conditions worsen or additional counties are added.

    The Bottom Line

    Oregon’s air quality advisory for wildfire smoke is active today and covers more than a dozen counties across eastern, central, and parts of western Oregon. For healthy adults, staying indoors with windows closed is the most effective response. For people with asthma, COPD, heart disease, children, pregnant people, and older adults, this advisory should be treated as a direct health warning: limit outdoor time, use HEPA filtration indoors, wear a properly fitted N95 if outdoor activity cannot be avoided, and monitor symptoms closely. Emergency care should be sought if respiratory or cardiovascular symptoms worsen despite precautions.

    Source link

  • Male Nurses Now Make Up 1 in 8 of the U.S. Nursing Workforce, with Growth Concentrated in Shortage Areas

    Male Nurses Now Make Up 1 in 8 of the U.S. Nursing Workforce, with Growth Concentrated in Shortage Areas

    Why This Matters

    Nursing is among the fastest-growing and most in-demand professions in the United States. The Labor Department projects 189,000 registered nurse job openings annually for the next decade. Emergency departments are understaffed. Rural hospitals are closing labor and delivery units. The healthcare system is looking everywhere for qualified nurses.

    Men make up approximately half the U.S. workforce, but only about 1 in 8 nurses. That gap represents not just an untapped workforce pipeline but a longstanding cultural assumption about nursing as women’s work that has depressed enrollment, discouraged qualified candidates, and narrowed the hiring pool for exactly the kind of work that is most urgently needed.

    According to NPR labor and workplace correspondent Andrea Hsu, that ratio is shifting. The male nursing share is growing, driven by a combination of strong job market conditions and deliberate recruitment efforts at nursing schools, particularly in the South.

    What We Know So Far

    NPR’s July 21, 2026 report focused on the University of Alabama at Birmingham School of Nursing, which has been among the institutions actively recruiting men into nursing. The UAB program has deployed direct outreach, male peer mentorship, and reframing of nursing as a high-skill, well-compensated healthcare leadership career rather than a gendered support role.

    Male nursing students interviewed for the NPR report described finding the work through pathways including athletic training, pharmacy interest, and military healthcare service, routes that have historically channeled men away from nursing rather than toward it.

    The data point at the center of the report, approximately 1 in 8 registered nurses is now male, reflects a long-term upward trend from roughly 1 in 40 male nurses in 1970. The increase has been gradual over decades, but recent years have shown an acceleration, particularly in states where nursing employment growth has been fastest.

    Where the Growth Is Most Significant

    The NPR report notes that the male nursing share is growing fastest in the South, a region that simultaneously has:

    • Some of the nation’s most severe nursing shortage conditions, particularly in rural areas
    • The highest rates of rural hospital closure and labor and delivery unit closures, as documented by the Center for Healthcare Quality and Payment Reform
    • Large unmet demand for primary care and emergency nursing staff, particularly in states including Alabama, Mississippi, Georgia, and the Carolinas
    • Among the highest rates of uninsured and underinsured populations, whose primary care needs fall disproportionately on nursing staff at federally qualified health centers and community clinics

    The UAB School of Nursing’s enrollment pattern mirrors a broader demographic shift: as healthcare jobs have become among the most stable, well-paying, and benefits-rich employment in the post-pandemic labor market, more men are reconsidering career paths that historically carried a gender stigma in their social and professional communities.

    What Doctors and Experts Say

    The nursing profession’s gender composition affects more than workforce numbers. Research on patient experience and care outcomes has found that patients benefit from a nursing workforce that reflects the demographic diversity of the population they serve, including gender diversity. Male patients in particular may be more comfortable discussing certain health concerns with male nurses. Men navigating chronic disease management, mental health issues, and preventive care are among the populations where male nurse-patient concordance may reduce barriers to disclosure.

    Nursing faculty and administrators quoted in the NPR report emphasized that the core skills of nursing, including clinical judgment, interpersonal communication, attention to detail, and ability to act effectively under pressure, have no gender component. The barriers have been cultural and representational, not competency-based.

    The Labor Department’s projection of 189,000 annual nursing job openings over the next decade reflects both retirements from an aging nursing workforce and growth in demand driven by an aging patient population. Those openings cannot be filled by any single demographic pipeline. Expanding the male nursing workforce is one necessary component of closing the gap.

    What the Evidence Shows and What It Does Not

    The 1-in-8 male nurse figure comes from workforce data reflecting the current registered nursing population. The NPR report does not provide a specific source for the exact figure beyond the framing in the headline and story; it is consistent with Bureau of Labor Statistics occupational workforce data showing male nurses at approximately 12-14% of the total registered nurse workforce in recent years.

    The claim that male nursing growth is happening “fastest in the South” is supported by the NPR reporting’s geographic focus on UAB and Southern nursing programs, but the NPR piece does not present state-by-state enrollment data. This is a directional claim supported by reported patterns, not a formally quantified regional ranking.

    MedicalDaily Evidence Check

    • Source: NPR, published July 21, 2026 (Andrea Hsu, labor and workplace correspondent); Labor Department occupational projections
    • What it shows: Approximately 1 in 8 registered nurses is male; the share is growing, with notable growth at Southern nursing programs; 189,000 annual RN job openings projected for next decade
    • What it does not prove: Specific state-by-state male enrollment rankings; whether the gender shift is driven by recruitment programs specifically vs. labor market forces generally
    • What readers should know: The nursing profession is actively seeking male applicants; the South’s nursing shortage means this growth is happening in the region where it is most needed

    Who Benefits Most?

    The workforce development implications of growing male nursing representation include:

    • Rural Southern communities, which have the highest unmet nursing demand and are seeing the fastest male nursing enrollment growth
    • Patients who prefer concordance-based care in specific clinical contexts, including men with mental health concerns, chronic disease, or situations requiring physical privacy during examination
    • The nursing profession itself, which benefits from a broader and more diverse recruitment pool as it faces sustained demographic attrition from retirement of the baby-boom nursing generation

    What You Can Do Now

    For people considering nursing as a career:

    For healthcare employers and policymakers:

    • Hospitals and health systems seeking to address nursing shortages can partner with regional nursing schools on recruitment pipeline programs that actively reach men in high school and early college years.
    • State-level workforce development funding through Title VIII nursing programs can support expanded nursing school capacity, particularly in shortage areas.

    Cost and Access: What Patients Should Know

    The nursing workforce shortage has direct effects on patient care: longer emergency department wait times, reduced availability of home health nursing, and reduced capacity for preventive and chronic disease management in underserved communities. Expanding the diversity and size of the nursing pipeline is a patient safety issue, not just a labor market issue.

    What Happens Next

    UAB and other Southern nursing programs with active male recruitment initiatives are expected to report enrollment trends annually. The Labor Department will update its occupational projections with 2025 and 2026 data in the coming years. Whether the male nursing share reaches 1 in 5 or higher within a decade will depend on whether the cultural shift documented in the NPR report extends beyond leading institutions and translates into broad enrollment patterns at community colleges and ADN programs that produce the largest total volume of nurses.

    The Bottom Line

    Approximately 1 in 8 U.S. registered nurses is now male, a share that is growing and growing fastest in the South, where nursing shortages are most acute. A strong job market, deliberate recruitment by nursing schools, and a gradual cultural shift in how nursing is understood as a profession are driving the change. With 189,000 RN job openings projected annually for the next decade, and with rural hospitals and clinics in the South facing the deepest shortfalls, the growth of male nursing in the region that needs nurses most is a workforce development trend worth watching.

    Source link

  • Male Nurses Now Make Up 1 in 8 of the U.S. Nursing Workforce, with Growth Concentrated in Shortage Areas

    Male Nurses Now Make Up 1 in 8 of the U.S. Nursing Workforce, with Growth Concentrated in Shortage Areas

    Why This Matters

    Nursing is among the fastest-growing and most in-demand professions in the United States. The Labor Department projects 189,000 registered nurse job openings annually for the next decade. Emergency departments are understaffed. Rural hospitals are closing labor and delivery units. The healthcare system is looking everywhere for qualified nurses.

    Men make up approximately half the U.S. workforce, but only about 1 in 8 nurses. That gap represents not just an untapped workforce pipeline but a longstanding cultural assumption about nursing as women’s work that has depressed enrollment, discouraged qualified candidates, and narrowed the hiring pool for exactly the kind of work that is most urgently needed.

    According to NPR labor and workplace correspondent Andrea Hsu, that ratio is shifting. The male nursing share is growing, driven by a combination of strong job market conditions and deliberate recruitment efforts at nursing schools, particularly in the South.

    What We Know So Far

    NPR’s July 21, 2026 report focused on the University of Alabama at Birmingham School of Nursing, which has been among the institutions actively recruiting men into nursing. The UAB program has deployed direct outreach, male peer mentorship, and reframing of nursing as a high-skill, well-compensated healthcare leadership career rather than a gendered support role.

    Male nursing students interviewed for the NPR report described finding the work through pathways including athletic training, pharmacy interest, and military healthcare service, routes that have historically channeled men away from nursing rather than toward it.

    The data point at the center of the report, approximately 1 in 8 registered nurses is now male, reflects a long-term upward trend from roughly 1 in 40 male nurses in 1970. The increase has been gradual over decades, but recent years have shown an acceleration, particularly in states where nursing employment growth has been fastest.

    Where the Growth Is Most Significant

    The NPR report notes that the male nursing share is growing fastest in the South, a region that simultaneously has:

    • Some of the nation’s most severe nursing shortage conditions, particularly in rural areas
    • The highest rates of rural hospital closure and labor and delivery unit closures, as documented by the Center for Healthcare Quality and Payment Reform
    • Large unmet demand for primary care and emergency nursing staff, particularly in states including Alabama, Mississippi, Georgia, and the Carolinas
    • Among the highest rates of uninsured and underinsured populations, whose primary care needs fall disproportionately on nursing staff at federally qualified health centers and community clinics

    The UAB School of Nursing’s enrollment pattern mirrors a broader demographic shift: as healthcare jobs have become among the most stable, well-paying, and benefits-rich employment in the post-pandemic labor market, more men are reconsidering career paths that historically carried a gender stigma in their social and professional communities.

    What Doctors and Experts Say

    The nursing profession’s gender composition affects more than workforce numbers. Research on patient experience and care outcomes has found that patients benefit from a nursing workforce that reflects the demographic diversity of the population they serve, including gender diversity. Male patients in particular may be more comfortable discussing certain health concerns with male nurses. Men navigating chronic disease management, mental health issues, and preventive care are among the populations where male nurse-patient concordance may reduce barriers to disclosure.

    Nursing faculty and administrators quoted in the NPR report emphasized that the core skills of nursing, including clinical judgment, interpersonal communication, attention to detail, and ability to act effectively under pressure, have no gender component. The barriers have been cultural and representational, not competency-based.

    The Labor Department’s projection of 189,000 annual nursing job openings over the next decade reflects both retirements from an aging nursing workforce and growth in demand driven by an aging patient population. Those openings cannot be filled by any single demographic pipeline. Expanding the male nursing workforce is one necessary component of closing the gap.

    What the Evidence Shows and What It Does Not

    The 1-in-8 male nurse figure comes from workforce data reflecting the current registered nursing population. The NPR report does not provide a specific source for the exact figure beyond the framing in the headline and story; it is consistent with Bureau of Labor Statistics occupational workforce data showing male nurses at approximately 12-14% of the total registered nurse workforce in recent years.

    The claim that male nursing growth is happening “fastest in the South” is supported by the NPR reporting’s geographic focus on UAB and Southern nursing programs, but the NPR piece does not present state-by-state enrollment data. This is a directional claim supported by reported patterns, not a formally quantified regional ranking.

    MedicalDaily Evidence Check

    • Source: NPR, published July 21, 2026 (Andrea Hsu, labor and workplace correspondent); Labor Department occupational projections
    • What it shows: Approximately 1 in 8 registered nurses is male; the share is growing, with notable growth at Southern nursing programs; 189,000 annual RN job openings projected for next decade
    • What it does not prove: Specific state-by-state male enrollment rankings; whether the gender shift is driven by recruitment programs specifically vs. labor market forces generally
    • What readers should know: The nursing profession is actively seeking male applicants; the South’s nursing shortage means this growth is happening in the region where it is most needed

    Who Benefits Most?

    The workforce development implications of growing male nursing representation include:

    • Rural Southern communities, which have the highest unmet nursing demand and are seeing the fastest male nursing enrollment growth
    • Patients who prefer concordance-based care in specific clinical contexts, including men with mental health concerns, chronic disease, or situations requiring physical privacy during examination
    • The nursing profession itself, which benefits from a broader and more diverse recruitment pool as it faces sustained demographic attrition from retirement of the baby-boom nursing generation

    What You Can Do Now

    For people considering nursing as a career:

    For healthcare employers and policymakers:

    • Hospitals and health systems seeking to address nursing shortages can partner with regional nursing schools on recruitment pipeline programs that actively reach men in high school and early college years.
    • State-level workforce development funding through Title VIII nursing programs can support expanded nursing school capacity, particularly in shortage areas.

    Cost and Access: What Patients Should Know

    The nursing workforce shortage has direct effects on patient care: longer emergency department wait times, reduced availability of home health nursing, and reduced capacity for preventive and chronic disease management in underserved communities. Expanding the diversity and size of the nursing pipeline is a patient safety issue, not just a labor market issue.

    What Happens Next

    UAB and other Southern nursing programs with active male recruitment initiatives are expected to report enrollment trends annually. The Labor Department will update its occupational projections with 2025 and 2026 data in the coming years. Whether the male nursing share reaches 1 in 5 or higher within a decade will depend on whether the cultural shift documented in the NPR report extends beyond leading institutions and translates into broad enrollment patterns at community colleges and ADN programs that produce the largest total volume of nurses.

    The Bottom Line

    Approximately 1 in 8 U.S. registered nurses is now male, a share that is growing and growing fastest in the South, where nursing shortages are most acute. A strong job market, deliberate recruitment by nursing schools, and a gradual cultural shift in how nursing is understood as a profession are driving the change. With 189,000 RN job openings projected annually for the next decade, and with rural hospitals and clinics in the South facing the deepest shortfalls, the growth of male nursing in the region that needs nurses most is a workforce development trend worth watching.

    Source link

  • Kate Middleton Opens Up About ‘Chemo Fog’ During Cancer Recovery: Understanding the Cognitive Effects of Chemotherapy

    Kate Middleton Opens Up About ‘Chemo Fog’ During Cancer Recovery: Understanding the Cognitive Effects of Chemotherapy

    Kate Middleton, the Princess of Wales, has shared new details about one of the most unexpected challenges she faced during her cancer treatment: the cognitive difficulties commonly known as “chemo fog” or “chemo brain.”

    Speaking candidly during a visit to a cancer treatment center, she described struggling to read and concentrate while undergoing chemotherapy, offering a glimpse into a side effect that many cancer patients experience but is often overlooked.

    Her remarks have resonated with patients, healthcare professionals and supporters alike, bringing renewed attention to the lasting mental and emotional effects that can accompany cancer treatment, even after therapy has ended.

    The Royal’s Reflection On Her ‘Chemo Fog’ Experience and an Unexpected Hobby She Gained

    While visiting patients at The Christie NHS Foundation Trust in Manchester, Kate reflected on the cognitive changes she experienced during chemotherapy. She explained that one of the most difficult aspects of treatment was her inability to focus on activities she had previously enjoyed.

    “I don’t know about you, but I didn’t have the ability to read or really focus on anything,” she shared while speaking with fellow patients.

    Instead of reading, Kate said she found comfort in an unexpected hobby: coloring. She explained that coloring allowed her to remain creative without the pressure of producing a finished piece.

    “[Coloring] was my way of exploring interesting things and being able to do something that did not require an end product, or an end finished piece,” she said.

    Kate, who announced she was in remission following her cancer treatment, has increasingly spoken about the realities of recovery, emphasizing that the journey does not end when chemotherapy is completed. Her openness has been widely praised by patients and advocacy groups, many of whom say it helps normalize conversations about the less visible side effects of cancer treatment.

    Peering Through the Chemo Fog

    According to the Mayo Clinic and the Cleveland Clinic, chemo fog, also known as chemo brain or cancer-related cognitive impairment, describes a collection of thinking and memory problems that may occur during or after cancer treatment.

    Although chemotherapy is commonly associated with the condition, experts believe cognitive changes may also result from several overlapping factors, including the cancer itself, radiation therapy, hormonal treatments, medications, fatigue, poor sleep, stress, anxiety, and depression.

    Common Symptoms

    People experiencing chemo fog may notice:

    • Difficulty concentrating
    • Memory lapses
    • Trouble finding the right words
    • Slower thinking or information processing
    • Difficulty multitasking
    • Problems staying organized
    • Shortened attention span
    • Mental fatigue

    Symptoms vary considerably between individuals. Some experience mild, temporary changes, while others continue to notice cognitive difficulties for months or even years after treatment.

    How Is It Diagnosed?

    There is no single test that confirms chemo fog.

    Healthcare providers typically diagnose it by:

    • Reviewing symptoms and medical history
    • Performing neurological and physical examinations
    • Assessing memory, attention, and executive function
    • Ruling out other possible causes such as thyroid disorders, vitamin deficiencies, depression or medication side effects

    Treatment and Management

    There is currently no specific cure for chemo fog, but many patients improve over time.

    Doctors often recommend strategies such as:

    • Treating underlying conditions like anemia or sleep disorders
    • Regular physical activity
    • Maintaining consistent sleep habits
    • Keeping calendars, reminders, and written notes
    • Completing mentally demanding tasks when energy levels are highest
    • Brain-training exercises and cognitive rehabilitation
    • Stress reduction through mindfulness or relaxation techniques

    Creative hobbies, which include drawing, coloring, puzzles or music, may also help some patients stay mentally engaged while reducing frustration, much like Kate described during her own recovery.

    A Hopeful Way to Cope With ‘Chemo Fog’ and Treating Cancer

    The Princess’ experience shines a light on a side effect of cancer treatment that many patients quietly endure. While hair loss, nausea and fatigue are widely recognized, cognitive changes can be equally disruptive, affecting work, family life and everyday activities long after treatment ends.

    Her willingness to discuss struggling with concentration and finding comfort through coloring may help reassure patients that these experiences are both common and valid. It also reinforces the importance of comprehensive cancer care that addresses emotional and cognitive recovery in addition to physical health.

    For the general public, Kate’s story offers greater understanding of the long-term challenges cancer survivors may face. For people undergoing chemotherapy, it serves as a reminder that recovery is often gradual, and seeking support for cognitive symptoms is just as important as managing the physical effects of treatment. With appropriate coping strategies, medical guidance, and patience, many individuals are able to regain confidence and improve their cognitive function as they continue their recovery journey.

    Source link

  • Returning to Play Safely: Angel Reese’s Recent Knee Injury and Why Medical Clearance Involves More Than Feeling Better

    Returning to Play Safely: Angel Reese’s Recent Knee Injury and Why Medical Clearance Involves More Than Feeling Better

    Atlanta Dream forward, Angel Reese, left Sunday’s WNBA game against the Chicago Sky after suffering a left leg injury during the fourth quarter, casting uncertainty over her availability as the league approaches All-Star festivities. Reese appeared to injure her knee after an awkward play near the basket, immediately grabbing at her left leg before needing assistance off the court.

    While initial updates suggested she was in good spirits following the game, her status remains dependent on further medical evaluation, underscoring why athletes should never rush back onto the court before receiving proper medical clearance.

    The Aftermath of the Injury from Awkward Footing

    The injury came at an unfortunate time for both Reese and the Atlanta Dream, as the rookie has become one of the team’s most influential players on both ends of the floor. Her absence not only affected the outcome of the contest but also raised questions about her availability for upcoming games and league events.

    As of now, there is no announced definitive diagnosis, but sports medicine experts generally emphasize that knee injuries require careful assessment before athletes resume basketball activities. Returning too early can increase the likelihood of worsening the original injury or developing additional damage to the ligaments, cartilage, or surrounding muscles.

    Understanding Knee Injuries in Basketball and Sports

    According to the Mayo Clinic Sports Medicine, the knee is one of the most commonly injured joints in athletes because it absorbs significant force during running, jumping, pivoting and sudden changes in direction. Basketball players are particularly vulnerable because of the sport’s frequent cutting movements, rapid acceleration and repeated landings.

    Common Causes

    Sports-related knee injuries may result from:

    • Sudden twisting or pivoting movements
    • Landing awkwardly after a jump
    • Direct blows or collisions
    • Overuse from repetitive training
    • Sudden changes in direction
    • Poor landing mechanics

    According to Mass General Brigham, common basketball injuries affecting the knee include ligament sprains such as ACL and MCL injuries, meniscus tears, patellar tendinitis (“jumper’s knee”), cartilage injuries, and bone bruises.

    Symptoms

    The symptoms vary depending on the injury but commonly include:

    • Immediate pain
    • Swelling
    • Difficulty bearing weight
    • Limited range of motion
    • Knee instability or “giving way”
    • Locking or catching sensations
    • Tenderness around the joint

    Diagnosis

    Doctors evaluate knee injuries through a combination of medical history and physical examination, assessing joint stability, strength and range of motion. Imaging studies, including X-rays to identify fractures and MRI scans to evaluate ligaments, cartilage, tendons and menisci, are commonly used when significant structural damage is suspected. In some cases, ultrasound or CT scans may also assist in diagnosis.

    Treatment

    The injury’s treatment depends on its severity and type. Mild sprains and overuse injuries often improve with:

    • Rest from sports activities
    • Ice application
    • Compression and elevation (RICE)
    • Anti-inflammatory medications when appropriate
    • Physical therapy to restore strength and mobility

    More significant ligament tears, tendon ruptures, or cartilage injuries may require bracing, injections, or surgical reconstruction followed by several months of rehabilitation before athletes can safely return to competition.

    Risk Factors

    Several factors increase the risk of knee injuries, including:

    • Participation in jumping and pivoting sports
    • Previous knee injuries
    • Muscle weakness or imbalance
    • Poor conditioning
    • Inadequate warm-up
    • Improper landing technique
    • Fatigue during competition

    Prevention

    Research on sports injury prevention shows that many knee injuries can be reduced through structured prevention programs. Recommended measures include:

    • Strengthening the hips, quadriceps, and hamstrings
    • Improving balance and neuromuscular control
    • Learning proper jumping and landing mechanics
    • Performing dynamic warm-ups before activity
    • Gradually increasing training intensity
    • Wearing appropriate footwear
    • Allowing sufficient recovery between intense workouts

    Medical Clearance Isn’t Just a Formality

    Angel Reese’s injury serves as a reminder that even elite athletes should not return to competition until healthcare professionals determine it is safe to do so. Medical clearance is more than a routine formality; it confirms that healing has progressed sufficiently for the knee to tolerate the physical demands of basketball without significantly increasing the risk of reinjury.

    For recreational athletes and weekend sports enthusiasts, the same principle applies. Continuing to play through knee pain or returning before strength, stability and mobility have recovered can prolong rehabilitation and increase the likelihood of chronic problems later in life.

    Be it playing professionally or casually, adequate rest, rehabilitation and adherence to medical advice remain among the most effective ways to protect long-term joint health. Reese’s experience highlights that prioritizing recovery today may ultimately allow athletes to perform more safely and successfully in the future.

    Source link

  • Returning to Play Safely: Angel Reese’s Recent Knee Injury and Why Medical Clearance Involves More Than Feeling Better

    Returning to Play Safely: Angel Reese’s Recent Knee Injury and Why Medical Clearance Involves More Than Feeling Better

    Atlanta Dream forward, Angel Reese, left Sunday’s WNBA game against the Chicago Sky after suffering a left leg injury during the fourth quarter, casting uncertainty over her availability as the league approaches All-Star festivities. Reese appeared to injure her knee after an awkward play near the basket, immediately grabbing at her left leg before needing assistance off the court.

    While initial updates suggested she was in good spirits following the game, her status remains dependent on further medical evaluation, underscoring why athletes should never rush back onto the court before receiving proper medical clearance.

    The Aftermath of the Injury from Awkward Footing

    The injury came at an unfortunate time for both Reese and the Atlanta Dream, as the rookie has become one of the team’s most influential players on both ends of the floor. Her absence not only affected the outcome of the contest but also raised questions about her availability for upcoming games and league events.

    As of now, there is no announced definitive diagnosis, but sports medicine experts generally emphasize that knee injuries require careful assessment before athletes resume basketball activities. Returning too early can increase the likelihood of worsening the original injury or developing additional damage to the ligaments, cartilage, or surrounding muscles.

    Understanding Knee Injuries in Basketball and Sports

    According to the Mayo Clinic Sports Medicine, the knee is one of the most commonly injured joints in athletes because it absorbs significant force during running, jumping, pivoting and sudden changes in direction. Basketball players are particularly vulnerable because of the sport’s frequent cutting movements, rapid acceleration and repeated landings.

    Common Causes

    Sports-related knee injuries may result from:

    • Sudden twisting or pivoting movements
    • Landing awkwardly after a jump
    • Direct blows or collisions
    • Overuse from repetitive training
    • Sudden changes in direction
    • Poor landing mechanics

    According to Mass General Brigham, common basketball injuries affecting the knee include ligament sprains such as ACL and MCL injuries, meniscus tears, patellar tendinitis (“jumper’s knee”), cartilage injuries, and bone bruises.

    Symptoms

    The symptoms vary depending on the injury but commonly include:

    • Immediate pain
    • Swelling
    • Difficulty bearing weight
    • Limited range of motion
    • Knee instability or “giving way”
    • Locking or catching sensations
    • Tenderness around the joint

    Diagnosis

    Doctors evaluate knee injuries through a combination of medical history and physical examination, assessing joint stability, strength and range of motion. Imaging studies, including X-rays to identify fractures and MRI scans to evaluate ligaments, cartilage, tendons and menisci, are commonly used when significant structural damage is suspected. In some cases, ultrasound or CT scans may also assist in diagnosis.

    Treatment

    The injury’s treatment depends on its severity and type. Mild sprains and overuse injuries often improve with:

    • Rest from sports activities
    • Ice application
    • Compression and elevation (RICE)
    • Anti-inflammatory medications when appropriate
    • Physical therapy to restore strength and mobility

    More significant ligament tears, tendon ruptures, or cartilage injuries may require bracing, injections, or surgical reconstruction followed by several months of rehabilitation before athletes can safely return to competition.

    Risk Factors

    Several factors increase the risk of knee injuries, including:

    • Participation in jumping and pivoting sports
    • Previous knee injuries
    • Muscle weakness or imbalance
    • Poor conditioning
    • Inadequate warm-up
    • Improper landing technique
    • Fatigue during competition

    Prevention

    Research on sports injury prevention shows that many knee injuries can be reduced through structured prevention programs. Recommended measures include:

    • Strengthening the hips, quadriceps, and hamstrings
    • Improving balance and neuromuscular control
    • Learning proper jumping and landing mechanics
    • Performing dynamic warm-ups before activity
    • Gradually increasing training intensity
    • Wearing appropriate footwear
    • Allowing sufficient recovery between intense workouts

    Medical Clearance Isn’t Just a Formality

    Angel Reese’s injury serves as a reminder that even elite athletes should not return to competition until healthcare professionals determine it is safe to do so. Medical clearance is more than a routine formality; it confirms that healing has progressed sufficiently for the knee to tolerate the physical demands of basketball without significantly increasing the risk of reinjury.

    For recreational athletes and weekend sports enthusiasts, the same principle applies. Continuing to play through knee pain or returning before strength, stability and mobility have recovered can prolong rehabilitation and increase the likelihood of chronic problems later in life.

    Be it playing professionally or casually, adequate rest, rehabilitation and adherence to medical advice remain among the most effective ways to protect long-term joint health. Reese’s experience highlights that prioritizing recovery today may ultimately allow athletes to perform more safely and successfully in the future.

    Source link

  • Going to Theaters, Museums, and Cinemas Regularly Is Linked to a Physiological Age 3 Years Younger, Study Finds

    Going to Theaters, Museums, and Cinemas Regularly Is Linked to a Physiological Age 3 Years Younger, Study Finds

    Older adults who regularly attend theaters, museums, cinemas, and concerts have a measurably lower physiological age than those who rarely participate in cultural activities, according to new research published in the Journal of Epidemiology and Community Health on July 14, 2026. The difference amounts to approximately three years of biological age, a gap that held up after researchers used a statistical technique to account for lifestyle factors and personal characteristics that remain constant over time.

    The study, led by researchers at the Institute of Science Tokyo in Japan, examined 1,899 adults aged 50 and older from the English Longitudinal Study of Ageing, a long-running nationally representative cohort that follows older adults in England with repeated health and lifestyle assessments across years.

    Why This Matters

    Biological aging is not the same as chronological aging. Two people who are both 70 years old can have bodies that function like those of a 65-year-old or a 75-year-old, depending on a complex mix of genetics, lifestyle, and lived experience. Physiological age, measured through biomarkers across multiple organ systems, is increasingly recognized as a more meaningful indicator of health trajectory than calendar age alone.

    The cultural engagement finding adds to a growing body of evidence that what people do with their time, particularly cognitive, social, and emotionally engaging activities, has measurable effects on how their bodies age. Theater, museum visits, concerts, and cinema are not typically thought of as health interventions. But this research suggests they may be functioning as one.

    “At the same time, I would emphasize that this was an observational study, so it does not prove that cultural engagement directly slows aging; healthier, more mobile, and more socially connected people may also be more likely to participate,” lead researcher Dr. Thi-Thuy-Linh Trinh told Medical News Today. “Still, the consistency of the findings over time makes cultural engagement a promising addition to broader healthy-aging strategies.”

    What We Know So Far

    The study used data from 1,899 adults who completed questionnaires about how often they visited cinemas, museums or art galleries, and theaters, concerts, or operas. Each activity was rated from 0 (never) to 5 (twice a month or more often), creating an overall cultural participation index of 0 to 15.

    Physiological age was calculated from ten physical measurements across five body systems: heart and circulation, lungs, blood, metabolism, and muscles and bones. This multimarker composite, drawn from standard clinical assessments, produces a biological age estimate that reflects functional wear-and-tear across the body.

    The key findings, as reported in ScienceDaily and the peer-reviewed PMC publication of the study:

    Adults with high levels of cultural engagement (participating in some cultural activity at least every few months) had an average physiological age of 66.9 years. Adults with low cultural engagement averaged a physiological age of 69.9 years, a gap of three years. Each one-point increase on the 0-to-15 cultural engagement score was associated with approximately a 0.085-year reduction in physiological age after adjustment. These associations held up cross-sectionally, at four-year follow-up, and at eight-year follow-up, and the pace of biological aging over four years was also slower in higher-engagement participants.

    The researchers used a fixed-effects statistical analysis, which controls for stable individual characteristics that do not change over time, including genetics, early life circumstances, and personality traits. This approach reduces (though does not eliminate) the risk that the observed association reflects selection bias rather than a real effect of cultural engagement on aging.

    Where the Research Was Conducted

    The English Longitudinal Study of Ageing is a nationally representative long-term study based in England, which means the findings come from a Western, predominantly English-speaking older adult population. Whether the results would generalize equally to culturally different settings or populations with different baseline access to cultural institutions is not established by this research.

    The study also found that individuals with higher cultural engagement were more likely to be women, have higher socioeconomic status, be in paid employment, and have better baseline health conditions. The fixed-effects analysis helps control for some of these factors, but the researchers acknowledge that reverse causation remains a concern: healthier people may simply be more able to attend cultural events rather than cultural attendance causing better health.

    What Doctors and Experts Say

    The study’s corresponding author, Dr. Yusuke Matsuyama of the Institute of Science Tokyo, published the findings alongside colleagues Sakura Kiuchi and Jun Aida. They proposed several plausible pathways through which cultural engagement might influence biological aging: stronger social ties from shared cultural experiences, better mental health through emotionally engaging activities, healthier behaviors associated with active cultural participation, and cognitive stimulation from exposure to art, narrative, and music.

    The authors noted that cultural engagement may be “comparable in impact to frequent physical activity” based on the effect size of the association. This comparison requires context: the researchers are not claiming cultural engagement replaces exercise, but rather that the magnitude of the physiological age association is in a similar range to what exercise studies have found using similar analytical frameworks.

    Medical News Today noted that Dr. Trinh advised expanding the research: “It would also be beneficial to explore the impact of different types and frequencies of cultural activities on biological age in diverse populations.”

    What the Evidence Shows and What It Does Not

    MedicalDaily Evidence Check

    • Study type: Longitudinal observational cohort study with fixed-effects analysis
    • Published in: Journal of Epidemiology and Community Health (BMJ Group), online July 14, 2026; doi: 10.1136/jech-2025-225753
    • Institution: Institute of Science Tokyo, Japan
    • Sample: 1,899 adults aged 50 and older from the English Longitudinal Study of Ageing
    • Key finding: High cultural engagement (at least every few months) associated with approximately 3-year lower physiological age; 0.085-year reduction in physiological age per 1-point increase in cultural engagement score
    • Statistical method: Fixed-effects analysis, which controls for time-stable confounders
    • Cultural activities measured: Cinema, museums/art galleries, theater/concerts/opera
    • What it shows: A consistent, longitudinally replicated association between cultural engagement and slower biological aging in older English adults
    • What it does not prove: That cultural engagement causes slower aging (causal inference is not possible from an observational study); whether results generalize to non-English or socioeconomically diverse populations
    • Key limitation: Participants with higher cultural engagement were more likely to be women, higher socioeconomic status, and in better baseline health; fixed-effects analysis addresses some but not all confounding
    • Reverse causation: Healthier people may be more able to attend cultural events, meaning the causal arrow could run in either direction
    • What readers should know: This study suggests cultural engagement is a worthwhile addition to a healthy-aging lifestyle. It is not evidence to skip other evidence-based interventions like physical activity, dietary quality, and sleep.

    Who Might Benefit Most

    This research is most directly relevant to:

    • Adults 50 and older who are making choices about how to spend leisure time and social energy
    • Clinicians and public health professionals designing healthy-aging programs and community interventions
    • Policymakers evaluating the health value of cultural institution funding and public arts programs
    • Older adults with limited physical mobility for whom high-intensity exercise may be difficult but cultural participation remains accessible

    The finding that the effect was seen across three types of cultural activities (cinema, museums, theater/concerts) suggests that the specific activity matters less than the general pattern of regular engagement.

    What You Can Do Now

    • If you are 50 or older and do not currently attend cultural events regularly, consider adding one to your routine. Cinema, museums, concerts, and theater are available in most urban and suburban areas, and many offer senior discounts or community-access programs.
    • For older adults with limited mobility, many museums and cultural institutions offer virtual access, audio tours, and home-delivery programs that allow engagement with cultural content without physical attendance.
    • Cultural engagement works best as part of a broader healthy-aging approach that also includes physical activity, quality sleep, social connection, and dietary quality. These are complementary, not competing, strategies.
    • For older adults in limited-access communities, many public libraries offer free or reduced-price passes to local museums and cultural institutions. Contact your local public library to ask about available programs.
    • Avoid interpreting this finding as a reason to prioritize cultural attendance over other established health behaviors. The evidence for physical activity, sleep, and nutrition is more robust and directly supported by intervention trials.

    Cost and Access: What Patients Should Know

    Access to cultural events varies significantly by geography and income. Major U.S. metro areas have large free or low-cost museum days, library pass programs, and community theater options. Rural areas face greater challenges. National programs including the National Endowment for the Arts and state arts councils support community arts programs that provide access in underserved communities. Many major art museums, including the Metropolitan Museum of Art and the Art Institute of Chicago, offer free general admission on certain days or to specific populations.

    What Happens Next

    The research team indicated interest in exploring the mechanisms underlying the association and studying diverse populations. Future research will need to test whether interventions that actively increase cultural engagement in older adults produce measurable biological improvements, moving from association to potential causation. MedicalDaily will report on any intervention trials in this space.

    The Bottom Line

    A longitudinal study of 1,899 English adults aged 50 and older found that regular cultural engagement, attending cinema, museums, theaters, and concerts at least every few months, was associated with a physiological age approximately three years lower than in those who rarely participated. The effect persisted across multiple follow-up waves. The observational design means causation cannot be established, and healthier people are more likely to participate in cultural activities in the first place. But the consistency of the association makes cultural engagement a reasonable addition to any evidence-based healthy-aging strategy, alongside physical activity, diet, sleep, and social connection.

    Source link